Byram W. Bridle

Rat genotype influences quantitative and qualitative aspects of xenogeneic immune response to pig blood mononuclear cells.

T lymphocyte subpopulations diverge in commercially raised chickens.

Deviation of xenogeneic immune response and bystander suppression in rats fed porcine blood mononuclear cells.

Steering orally induced deviation of xenogeneic immunity with exogenous cytokines in rats fed porcine proteins.

Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine.

Maraba virus as a potent oncolytic vaccine vector.

Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination.

Replication and Oncolytic Activity of an Avian Orthoreovirus in Human Hepatocellular Carcinoma Cells.

Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.

Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections.

Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission.

Maraba virus-vectored cancer vaccines represent a safe and novel therapeutic option for cats.

Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies.

Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer.

Use of Precision-Cut Lung Slices as an Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy.

Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer.

Development and applications of oncolytic Maraba virus vaccines.

Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies.

Myeloid Cells during Viral Infections and Inflammation.

AAV-mediated expression of 3TSR inhibits tumor and metastatic lesion development and extends survival in a murine model of epithelial ovarian carcinoma.

Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies.

Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination.

SR9009 administered for one day after myocardial ischemia-reperfusion prevents heart failure in mice by targeting the cardiac inflammasome.

Optimized Pre-Clinical Grade Production of Two Novel Lentiviral Vector Pseudotypes for Lung Gene Delivery.

Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning.

Tumour vasculature: Friend or foe of oncolytic viruses?

AAV Vectored Immunoprophylaxis for Filovirus Infections.

Type I Interferon α/β Receptor-Mediated Signaling Negatively Regulates Antiviral Cytokine Responses in Murine Bone-Marrow-Derived Mast Cells and Protects the Cells from Virus-Induced Cell Death.

Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models.

Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils.

The Role of Type I Interferon Signaling in Regulating Cytokine Production and Cell Survival in Bone Marrow-Derived Macrophages.